John Lunger
Overview
John Lunger received an average of $1M in total compensation, including $399K in salary, at Adaptimmune Therapeutics from 2019 to 2021.
Source: SEC filing on April 21, 2022.
Related executives
We found six more executives who work or worked at Adaptimmune Therapeutics.
Adrian Rawcliffe
Adaptimmune Therapeutics
Chief Executive Officer
Helen Tayton-Martin
Adaptimmune Therapeutics
Chief Business Officer
William Bertrand
Adaptimmune Therapeutics
Chief Operating Officer
Gavin Wood
Adaptimmune Therapeutics
Chief Financial Officer
James Noble
Adaptimmune Therapeutics
Chief Executive Officer
Rafael Amado
Adaptimmune Therapeutics